Title : [Treatment of Alzheimer's disease: acetylcholinesterase inhibitors].

Pub. Date : 1999 Apr

PMID : 10363493






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Donepezil is a specific, reversible acetylcholinesterase inhibitor of close to 100% absorption and a half-life of 70 h, achieving stable concentrations at approximately 3 weeks. Donepezil acetylcholinesterase (Cartwright blood group) Homo sapiens
2 CONCLUSIONS: Different studies carried out with the acetylcholinesterase inhibitors donepezil, rivastigmine and metriphonate have been effective in the control of the cognitive symptoms of Alzheimer disease in the initial or moderate phases of the disease. Donepezil acetylcholinesterase (Cartwright blood group) Homo sapiens